Evidence map›Paper›PMID 26369983›Full record

ArticleLeukemia2015

Presence of polyclonal hematopoiesis in females with Ph-negative myeloproliferative neoplasms.

S Swierczek, L T Lima, T Tashi, S J Kim, X T Gregg, J T Prchal

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

S SwierczekDivision of Hematology, Internal Medicine Department, University of Utah and VAH, Salt Lake City, UT, USA.
L T LimaDivision of Hematology, Internal Medicine Department, University of Utah and VAH, Salt Lake City, UT, USA.
T TashiDivision of Hematology, Internal Medicine Department, University of Utah and VAH, Salt Lake City, UT, USA.
S J KimDivision of Hematology, Internal Medicine Department, University of Utah and VAH, Salt Lake City, UT, USA.
X T GreggUtah Cancer Specialists, Salt Lake City, UT, USA.
J T PrchalDivision of Hematology, Internal Medicine Department, University of Utah and VAH, Salt Lake City, UT, USA.
University of Utah · USUtah Cancer Specialists · US

Funding

Tissue BankP01CA108671 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Ronald Hoffman · 2006 to 2026
$82.0M
NCI NIH HHS P01 CA108671NCI NIH HHS P01CA108671
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HematopoiesisPhiladelphia ChromosomeCalreticulinFemaleHumansJanus Kinase 2Receptors, ThrombopoietinThrombocythemia, EssentialCalreticulinJAK2 protein, humanJanus Kinase 2MPL protein, humanReceptors, Thrombopoietin

Identifiers

PMID26369983
PMCPMC5083033
OpenAlexW2238987169

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.